Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. The company's lead product candidate is resecabtagene autoleucel, a ...
Leadership
Steven A. Nichtberger M.D.Founder
Co-Founder, Chairman, CEO & President
David J. Chang FACR, M.D., M.P.H.
Chief Medical Officer
Gwendolyn K. Binder Ph.D.
President of Science & Technology
Michael C. Milone M.D., Ph.D.Founder
Co-Founder & Co-Chair of Scientific Advisory Board
Aimee Payne M.D., Ph.D.Founder
Co-Founder & Co-Chair of Scientific Advisory Board
